According to Research by SNS Insider, Nebulizer Market Growth is Driven by Rising Prevalence of Chronic Respiratory Diseases and Technological Advancements.Austin, Oct. 18, 2024 (GLOBE NEWSWIRE) -- ...

Dr Shiv Tej N and Dr Venugopal Reddy I, members of the Pediatric Team at Ovum Woman and Child Hospital, Bangalore, explain ...

Depemokimab has already shown its potential as a therapy for severe asthma in two other phase 3 trials – SWIFT-1 and SWIFT-2 ...

Passionate about returning Big Pharma's power to the people, Marc DeValera, founder of MLFD-MedTech Inc., developed 3 ...

Background Nausea and vomiting is a common ED chief complaint. However, randomised trials comparing antiemetic agents to placebo have not demonstrated superiority. This systematic review investigates ...

The medicines for which the prices have been increased are not very expensive to begin with and are not expected to hit ...

For four years, doctors told Lori Morris she had asthma; all the while, lung cancer slowly spread throughout her body.

GSK’s follow-up to its severe asthma therapy Nucala has shown its value in a pair of phase 3 trials, reducing exacerbations compared to placebo with dosing once every six months. The company ...

Asthma is a chronic respiratory condition that affects many children worldwide, causing inflammation and narrowing of the ...

The National Pharmaceutical Pricing Authority (NPPA) has sanctioned the ceiling price hike for 11 formulations by 50 per cent ...

The medicines for which the prices have been increased are not very expensive to begin with and are not expected to hit ...